Drug-Coated Balloons: Current Outcomes and Future Directions

Ananya Kondapalli, Barbara A. Danek, Houman Khalili, Haekyung Jeon-Slaughter, Subhash Banerjee

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

Original languageEnglish (US)
Pages (from-to)217-225
Number of pages9
JournalInterventional Cardiology Clinics
Volume6
Issue number2
DOIs
StatePublished - Apr 1 2017

Fingerprint

Paclitaxel
Arteries
Balloon Angioplasty
Peripheral Arterial Disease
Pharmaceutical Preparations
Direction compound

Keywords

  • Drug-coated balloons
  • Endovascular intervention
  • Femoropopliteal peripheral artery
  • Infrapopliteal peripheral artery
  • Paclitaxel

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Drug-Coated Balloons : Current Outcomes and Future Directions. / Kondapalli, Ananya; Danek, Barbara A.; Khalili, Houman; Jeon-Slaughter, Haekyung; Banerjee, Subhash.

In: Interventional Cardiology Clinics, Vol. 6, No. 2, 01.04.2017, p. 217-225.

Research output: Contribution to journalReview article

Kondapalli, Ananya ; Danek, Barbara A. ; Khalili, Houman ; Jeon-Slaughter, Haekyung ; Banerjee, Subhash. / Drug-Coated Balloons : Current Outcomes and Future Directions. In: Interventional Cardiology Clinics. 2017 ; Vol. 6, No. 2. pp. 217-225.
@article{9563123564d34205bde2b5bfedcf26f7,
title = "Drug-Coated Balloons: Current Outcomes and Future Directions",
abstract = "Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.",
keywords = "Drug-coated balloons, Endovascular intervention, Femoropopliteal peripheral artery, Infrapopliteal peripheral artery, Paclitaxel",
author = "Ananya Kondapalli and Danek, {Barbara A.} and Houman Khalili and Haekyung Jeon-Slaughter and Subhash Banerjee",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.iccl.2016.12.005",
language = "English (US)",
volume = "6",
pages = "217--225",
journal = "Interventional Cardiology Clinics",
issn = "2211-7458",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Drug-Coated Balloons

T2 - Current Outcomes and Future Directions

AU - Kondapalli, Ananya

AU - Danek, Barbara A.

AU - Khalili, Houman

AU - Jeon-Slaughter, Haekyung

AU - Banerjee, Subhash

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

AB - Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

KW - Drug-coated balloons

KW - Endovascular intervention

KW - Femoropopliteal peripheral artery

KW - Infrapopliteal peripheral artery

KW - Paclitaxel

UR - http://www.scopus.com/inward/record.url?scp=85009496035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009496035&partnerID=8YFLogxK

U2 - 10.1016/j.iccl.2016.12.005

DO - 10.1016/j.iccl.2016.12.005

M3 - Review article

C2 - 28257769

AN - SCOPUS:85009496035

VL - 6

SP - 217

EP - 225

JO - Interventional Cardiology Clinics

JF - Interventional Cardiology Clinics

SN - 2211-7458

IS - 2

ER -